Yulai Zhou

1.9k total citations
69 papers, 1.5k citations indexed

About

Yulai Zhou is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yulai Zhou has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 11 papers in Immunology and 9 papers in Oncology. Recurrent topics in Yulai Zhou's work include Cancer-related molecular mechanisms research (7 papers), Ubiquitin and proteasome pathways (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Yulai Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Ubiquitin and proteasome pathways (6 papers) and Multiple Myeloma Research and Treatments (6 papers). Yulai Zhou collaborates with scholars based in China, United States and Hong Kong. Yulai Zhou's co-authors include Yetong Feng, Lei Zhao, Hao Zhang, Pengfei Liu, Yong Xu, Yan Zhang, Xiaoqian Xue, Jiuwei Cui, Hong Shen and Pengfei Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and PLoS ONE.

In The Last Decade

Yulai Zhou

67 papers receiving 1.5k citations

Peers

Yulai Zhou

IMMUN

ONCOL

PRM

Yan Du China

Jing Jiang China

Weidong Jiang China

Cláudio J. Maia Portugal

Jingping Hu China

Mehdi Talebi Iran

Luiz Eurico Nasciutti Brazil

Francisco Dası́ Spain

Shing‐Jyh Chang Taiwan

Wenxin Song United States

Yan Du China

Yulai Zhou

649 ×0.9

256 ×1.2

317 ×1.5

IMMUN

321 ×1.6

ONCOL

194 ×1.0

PRM

Citations per year, relative to Yulai Zhou Yulai Zhou (= 1×) peers Yan Du

Countries citing papers authored by Yulai Zhou

Since Specialization

Citations

This map shows the geographic impact of Yulai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulai Zhou more than expected).

Fields of papers citing papers by Yulai Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulai Zhou. The network helps show where Yulai Zhou may publish in the future.

Co-authorship network of co-authors of Yulai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yulai Zhou. A scholar is included among the top collaborators of Yulai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulai Zhou. Yulai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yulai, Yan Gao, Yinghui Peng, et al.. (2025). QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axis. Cell Death Discovery. 11(1). 192–192. 5 indexed citations

Gao, Yan, Yinghui Peng, Yulai Zhou, et al.. (2025). HMBOX1 reverses autophagy mediated 5-fluorouracil resistance through promoting HACE1-induced ubiquitination and degradation of ATG5 in colorectal cancer. Autophagy. 21(7). 1556–1577. 5 indexed citations

Yang, Shuai, Yong Zhang, Yanan Li, et al.. (2025). Association of Maternal Thyroglobulin Antibody With Preterm Birth in Euthyroid Women. The Journal of Clinical Endocrinology & Metabolism. 110(11). e3841–e3849. 1 indexed citations

Zhou, Yulai, et al.. (2024). A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses. Nature Immunology. 25(8). 1489–1506. 23 indexed citations

Zhou, Yulai, Xiangyang Zhang, Yan Gao, et al.. (2024). Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer. iScience. 27(7). 110318–110318. 3 indexed citations

Yang, Xi, Yulai Zhou, Huan Li, et al.. (2022). Autophagic flux inhibition, apoptosis, and mitochondrial dysfunction in bile acids‐induced impairment of human placental trophoblast. Journal of Cellular Physiology. 237(7). 3080–3094. 13 indexed citations

Cai, Changjing, Yinghui Peng, Edward Shen, et al.. (2022). Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model. EBioMedicine. 76. 103866–103866. 17 indexed citations

Guo, Fei, et al.. (2021). Thyroxine Supplementation in Pregnant Women After Thyroidectomy for Thyroid Cancer and Neonatal Birth Weight. Frontiers in Endocrinology. 12. 728199–728199. 4 indexed citations

Akimoto, Jun, Hideyuki Miyatake, Seiichi Tada, et al.. (2019). Cell migration and growth induced by photo-immobilised vascular endothelial growth factor (VEGF) isoforms. Journal of Materials Chemistry B. 7(27). 4272–4279. 9 indexed citations

10.

Huang, Yu, Chun Zhang, & Yulai Zhou. (2019). LncRNA MIR100HG promotes cancer cell proliferation, migration and invasion in laryngeal squamous cell carcinoma through the downregulation of miR-204-5p. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Xiang, Qiuping, Yan Zhang, Xiaoqian Xue, et al.. (2018). Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer. ACS Medicinal Chemistry Letters. 9(3). 262–267. 20 indexed citations

12.

Zhang, Yan, Ming Song, Xiaoqian Xue, et al.. (2018). Structure-Based Discovery and Optimization of Benzo[d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). Journal of Medicinal Chemistry. 61(7). 3037–3058. 49 indexed citations

13.

Li, Chenxu, Shubin Chen, Yulai Zhou, et al.. (2018). Application of induced pluripotent stem cell transplants: Autologous or allogeneic?. Life Sciences. 212. 145–149. 21 indexed citations

14.

Liu, Pengfei, Yetong Feng, Delu Dong, et al.. (2016). Enhanced renoprotective effect of IGF-1 modified human umbilical cord-derived mesenchymal stem cells on gentamicin-induced acute kidney injury. Scientific Reports. 6(1). 20287–20287. 44 indexed citations

15.

Liu, Pengfei, Yetong Feng, Yi Wang, Yulai Zhou, & Lei Zhao. (2015). Protective effect of vitamin E against acute kidney injury. Bio-Medical Materials and Engineering. 26(1_suppl). S2133–44. 29 indexed citations

16.

Lv, Mingyu, Biao Zhang, Han Zhu, et al.. (2015). Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation. Scientific Reports. 5(1). 11736–11736. 31 indexed citations

17.

Chen, Yanyan, Dejun Sun, Yulai Zhou, et al.. (2014). Cloning, Expression and Characterization of a Novel Thermophilic Polygalacturonase from Caldicellulosiruptor bescii DSM 6725. International Journal of Molecular Sciences. 15(4). 5717–5729. 21 indexed citations

18.

Wei, Wei, Haoran Guo, Jingliang Li, et al.. (2014). Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV-A16. PLoS ONE. 9(4). e94746–e94746. 21 indexed citations

19.

Jia, Hui, Jiao Wang, Yuanyuan Jia, et al.. (2010). Method to construct tissue engineering corneal stroma with bacterial cellulose and its evaluation. 36(2). 303–307. 1 indexed citations

20.

Xu, Hui, Yulai Zhou, Jingmin Zhang, et al.. (2007). Effects of fluoride on the intracellular free Ca2+ and Ca2+-ATPase of kidney. Biological Trace Element Research. 116(3). 279–287. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact